Outreach & Education

To effectively serve our target populations for hepatitis B and hepatitis C, we work with community leaders and bilingual physicians to explore and use culturally and linguistically appropriate outreach and education materials. Community leaders advise and assist HBI-DC on the best approaches to reach and educate the target audience through ethnic media, such as TV, radio, newspapers, and social media.
We have utilized various media outlets to raise awareness about viral hepatitis, liver diseases, and HIV with a goal of encouraging new patients to attend in-person and online education seminars and participate in our in-person and online screening events. HBI-DC also utilizes the assistance of bi- and multilingual volunteers to help with translation and interpretation services when needed.

At-Risk Communities

Hepatitis B and C are silent epidemics that can cause lifelong infection, cirrhosis (scarring) of the liver, liver cancer, liver failure, and death. Although Asian Americans and Pacific Islanders (AAPIs) represent less than 5% of the total US population, they account for 50% of nearly one million Americans living with chronic Hepatitis B and 27% of the almost 1,700 deaths resulting from chronic hepatitis B infection in the United States.

There are approximately 3.5 million Americans with chronic hepatitis C. The communities from China, Southeast Asia, most of Africa, and most Pacific Islands have all been identified as areas with a high prevalence for the Hepatitis B virus, with 8-15% of the population being carriers for the virus. The most recent data has shown that in the Washington, DC area African immigrants comprise 17% of the District’s immigrant population and the AAPI community encompasses 10% of the metropolitan area’s overall population.

Chronic infection with the hepatitis B virus (HBV) and/or the hepatitis C virus (HCV) are among the highest risk factors for causing liver cancer within the US. Cancer is the leading cause of death among AAPIs, accounting for 27% of all deaths, with liver cancer being the second highest cause of cancer death (14%). According to current research, the Laotian, Vietnamese, and Cambodian communities are identified as having particularly elevated rates of liver cancer due to the high prevalence of HBV in their country of origin and more recent immigration.

Hepatitis FAQ

Hepatitis B is a contagious liver disease that results from an infection by the hepatitis B virus (HBV). It can range in severity from being a mild ailment lasting a few weeks to a serious, even life threatening, lifelong illness. With proper treatment, it can be managed. Also, for many people, getting the hepatitis B vaccination can prevent them from getting HBV. You should get tested to know for sure if you have hepatitis B.

While anyone can get Hepatitis B, Asian and Pacific Islanders (APIs) account for more than 50% of Americans with chronic Hepatitis B. There are several ways through which Hepatitis B infections can occur; most APIs with Hepatitis B in the US were infected as infants or young children.

The hepatitis B virus (HBV) is transmitted through blood and infected body fluids. Transmission can occur through:

  • Direct blood to blood contact
  • Unprotected sex
  • Use of unsterile needles
  • From an infected mother to her newborn child through the delivery process

Hepatitis C is a contagious liver disease that ranges in severity from a mild illness lasting a few weeks to a serious, lifelong illness that attacks the liver. It results from infection with the hepatitis C virus (HCV), which is spread primarily through contact with the blood of an infected person. HCV can be either “acute” or “chronic.”

  • Acute HCV infection is a short-term illness that occurs within the first 6 months after someone is exposed to HCV. For most people, acute infection leads to chronic infection.
  • Chronic HCV infection is a long-term illness that occurs when the hepatitis C virus remains in a person’s body. HCV infection can last a lifetime and lead to serious liver problems, including cirrhosis (scarring of the liver) or liver cancer.

According to CDC’s April 2020 recommendations for Hepatitis C Screening Among Adults, anyone 18 or over should get screened for HCV at least once in their lifetime. All pregnant women during each pregnancy, except in settings where the prevalence of HCV infection is <0.1%, should also be screened. Also, talk to your doctor about being tested for Hepatitis C if any of the following are true:

  • You were born from 1945 through 1965.
  • You are a current or former injection drug user, even if you injected only one time or many years ago.
  • You were treated for a blood clotting problem before 1987.
  • You received a blood transfusion or organ transplant before July 1992.
  • You are on long-term hemodialysis treatment.
  • You have abnormal liver tests or liver disease.
  • You work in health care or public safety and were exposed to blood through a needlestick or other sharp object injury.
  • You are infected with HIV.

People can become infected with the HCV during such activities as:

  • Sharing needles, syringes, or other equipment to inject drugs
  • Needlestick injuries in health care settings
  • Being born to a mother who has Hepatitis C

Less commonly, a person can also get HCV infection through:

  • Sharing personal care items that may have come in contact with another person’s blood, such as razors or toothbrushes
  • Having sexual contact with a person infected with HCV

While most healthy adults recover and develop antibodies to the hepatitis B virus, long term infection can lead to serious and debilitating liver damage including cirrhosis, cancer and even death.

Chronic Hepatitis C is a serious disease that can result in long-term health problems, including liver damage, liver failure, liver cancer, or even death.

Approximately 1 in 12 Asian Americans and Pacific Islanders (APIs) are living with chronic Hepatitis B, but most do not know it. Hepatitis B-related liver cancer incidence is highest among APIs. It is a leading cause of cancer deaths in this population. The death rate from Hepatitis B among APIs is 7 times greater than rates among whites.

Chronic Hepatitis C is the leading cause of cirrhosis and liver cancer for any ethnicity and the most common reason for liver transplantation in the United States. Approximately 19,000 people die every year from Hepatitis C related liver disease.

A person can have the virus and not have any visible symptoms, or have symptoms so mild they are often overlooked. The only sure way to know if you have Hepatitis B or C is to have a blood test that specifically checks for the virus. Because many doctors do not see the virus as being a problem in other countries, and are unaware of the serious threat posed by Hepatitis B and C, you may have to insist on specific screening for it.

If, after careful screening it is determined that you are indeed infected, see your doctor promptly. He or she would be the best source of advice and treatment.

There is no cure for Hepatitis B, but there is a cure for Hepatitis C. While Hepatitis B cannot be cured, it can be successfully treated. Medical treatment and a proper lifestyle can help someone with the virus live an otherwise full, healthy life.

Acute and chronic Hepatitis C can be treated. Acute infection can clear on its own without treatment in about 25% of people. If acute hepatitis C is diagnosed, treatment does reduce the risk that acute hepatitis C will become a chronic infection. Acute hepatitis C is treated with the same medications used to treat chronic Hepatitis C. However, the optimal treatment and when it should be started remains uncertain. There are several medications available to treat chronic Hepatitis C, including new treatments that appear to be more effective and have fewer side effects than previous options.

Health Screenings

HBI-DC offers free hepatitis B, hepatitis C, and HIV screenings in DC, Maryland, and Virginia. We utilize our diverse partnerships to offer our services at health fairs, community events, and religious gatherings. Our mobile unit allows us to offer our services in other hard-to-reach parts of the DMV.

HBI-DC encourages targeted at-risk populations to know their health status. HBI-DC offers free hepatitis B, hepatitis C, HIV, BMI, glucose, and cholesterol screenings to provide patients with a more comprehensive health screening. This approach also takes away a layer of stigma that might be associated with getting tested for viral hepatitis and HIV.

All screening results are stored in a HIPAA compliant database.

HBI-DC is offering hybrid screening model.  Please fill out our online registration and consent form and a staff member will reach out to you for scheduling an appointment for a test at the nearest to you LabCorp location.



A key aspect in addressing hepatitis B is ensuring patients are vaccinated against the virus to prevent contraction of the disease. For each patient screened for the hepatitis B virus, HBI-DC tests additionally for the presence of a vaccine (the hepatitis B antibody) within the patient. Patients identified as needing vaccines are then provided additional resources on the importance of vaccination and locations to receive these services. HBI-DC is proud to partner with local pharmacies, clinics, and physician networks to provide free or low-cost vaccines to these identified patients.

Linkage to Care

We provide linkage to care and patient navigation services in multiple languages to assist in the procurement of treatment services and drug assistance programs. Our staff are trained to be HIPAA compliant to facilitate this process. We have developed a comprehensive network of primary care providers, insurance and pharmaceutical companies that aids patients in navigating the health care system. »View our partners via this link.


Find more information about Hep B & C and other related topics:
Hepatitis B
Public Policy
  • AAPCHO (Association of Asian Pacific Community Health Organizations)
  • MOAA (DC Mayor’s Office on African Affairs)
  • MOAPIA (DC Mayor’s Office on Asian and Pacific Islander Affairs)
World Hepatitis Alliance
Scroll to Top
Scroll to Top